Medicare doesn’t pay for obesity drugs: lifting this coverage prohibition faces considerable hurdles

Forbes

11 March 2023 - A number of different stakeholders across the healthcare landscape are lobbying legislators and the Centers for Medicare and Medicaid Services to change statutory rules prohibiting Medicare coverage of obesity drugs. 

These 20 year old statutes were put in place prior to obesity being defined as a disease in 2013, and the advent of improved weight loss therapeutics in 2014, and most recently in 2021.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Market access , Medicare